Abstract

Keratoconus (KC) is classically considered a non-inflammatory condition caused by central corneal thinning that leads to astigmatism and reduced visual acuity. Previous studies have identified increased systemic levels of pro-inflammatory factors, including interleukin-6, tumor necrosis factor-α, and matrix metalloproteinase-9, suggesting that KC may have an inflammatory component in at least a subset of patients. In this study, we evaluated the levels of different immunoglobulins (light and heavy chains) based on Ig α, Ig λ, Ig κ, Ig µ, and Ig heavy chain subunits in non-KC tears (n = 7 control individuals) and KC tears (n = 7 KC patients) using tandem-liquid chromatography mass spectrometry. The most abundant Ig heavy chains detected in both control individuals and KC patients were Ig α-1 and Ig α-2 likely correlating to the higher IgA levels reported in human tears. We identified significant differences in immunoglobulin κ-chain V-II levels in KC patients compared to control individuals with no significant difference in Ig κ/Ig λ ratios or heavy chain levels. Our study supports previous findings suggesting that KC possesses a systemic component that may contribute to the KC pathology. Further studies are required to define causality and establish a role for systemic immune system-dependent factors and pro-inflammatory processes in KC development or progression.

Details

Title
Characterization of Tear Immunoglobulins in a Small-Cohort of Keratoconus Patients
Author
McKay, Tina B 1 ; Serjersen Henrik 2 ; Hjortdal Jesper 2 ; Zieske, James D 1 ; Karamichos Dimitrios 3 

 Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Aarhus University Hospital, Department of Ophthalmology, Aarhus, Denmark (GRID:grid.154185.c) (ISNI:0000 0004 0512 597X) 
 University of North Texas Health Science Center, North Texas Eye Research Institute, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057); University of North Texas Health Science Center, Department of Pharmaceutical Sciences, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057); University of North Texas Health Science Center, Department of Pharmacology and Neuroscience, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2412149784
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.